Abbott Medical Devices
abbott.comTotal trials
535
Active
67
Phase 3
18
Total enrollment
332,023
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Non-Vitamin K Oral Antagonists | — | — | — | — | — | 1 |
Next readouts
- 2029-01
Top conditions
- Heart Failure85
- Coronary Artery Disease72
- Atrial Fibrillation34
- Coronary Disease28
- Bradycardia25
- Coronary Restenosis23
- Coronary Artery Stenosis23
- Myocardial Ischemia20
Frequently asked questions about Abbott Medical Devices
- How many clinical trials does Abbott Medical Devices have on ClinicalTrials.gov?
- Abbott Medical Devices is listed as the lead sponsor on 535 clinical trials in ClinicalTrials.gov, 67 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Abbott Medical Devices's trials are in Phase 3?
- 18 of Abbott Medical Devices's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Abbott Medical Devices focus on?
- Abbott Medical Devices's most-studied conditions on ClinicalTrials.gov are Heart Failure, Coronary Artery Disease, Atrial Fibrillation, Coronary Disease, Bradycardia.
- When are Abbott Medical Devices's next clinical trial readouts?
- Abbott Medical Devices has 1 upcoming primary-completion readout tracked here; the soonest is “Amplatzer Amulet LAAO vs. NOAC”, expected around 2029-01.